Top Markets
#1 Cysic Cysic +7.96%
#2 Palladium Network Palladium Network +6.82%
#3 Pieverse Pieverse +3.88%
#4 KOTAI KOTAI +2.16%
#5 Akedo Akedo +2.15%
#6 Bless Bless +1.27%
#7 aPriori aPriori +1.17%
#8 Prom Prom +1.16%
#9 Zest Protocol Zest Protocol +1.01%
#10 Test Test +0.95%
Coin of the day
Cysic Cysic
Settings
Language
ENGLISH
Currency
USD
Theme
IR-Med Inc. IR-Med Inc.

IR-Med Inc.

IRME
Rank in Stocks #40380
IR-Med Inc. is an emerging medical technology firm dedicated to developing... IR-Med Inc. is an emerging medical technology firm dedicated to developing advanced diagnostic and medical solutions by leveraging a platform that integrates infra-red light spectroscopy with artificial intelligence. The company's product pipeline includes PressureSafe, a handheld optical monitoring device engineered for the early identification of pressure-induced tissue damage in the skin and subcutaneous layers, often resulting from extended periods of patient immobility. Additionally, IR-Med is developing Nobiotics, an innovative otoscope designed to provide medical professionals with immediate feedback on the presence of middle ear infections (Otitis Media), a prevalent condition among pediatric patients. IR-Med Inc. operates from its headquarters in Rosh Pina, Israel.
Share Price
$0.0021
Last synced: 2026-08-12
Market Cap
$162.20K
Change (1 day)
0.00%
Change (1 year)
-88.20%
Country
IL
Trade IR-Med Inc. (IRME)

Category

Healthcare
Revenue for IR-Med Inc. (IRME)
Revenue in Aug 2026 TTM: 0
According to IR-Med Inc. latest financial reports the company's current revenue (TTM) is 0. In 2026 the company made a revenue of 0 equal to the revenue in the year 2026 that was 0. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for IR-Med Inc. from 2026 to 2026
Revenue at the end of each year
Year Revenue Change
Not enough data for the provided dates.
Revenue for similar companies or competitors
Company Revenue Revenue Difference Country
Abbott Laboratories Abbott Laboratories
Abbott Laboratories
ABT.US
 $46.59B -
US
Stryker Corporation Stryker Corporation
Stryker Corporation
SYK.US
 $25.84B -
US
Medtronic plc Medtronic plc
Medtronic plc
MDT.US
 $35.48B -
IE
Boston Scientific Corporation Boston Scientific Corporation
Boston Scientific Corporation
BSX.US
 $21.00B -
US
Edwards Lifesciences Corporation Edwards Lifesciences Corporation
Edwards Lifesciences Corporation
EW.US
 $6.51B -
US